Filing Details

Accession Number:
0000899243-17-028237
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-12-08 16:05:52
Reporting Period:
2017-12-07
Accepted Time:
2017-12-08 16:05:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
31791 Perkinelmer Inc PKI Laboratory Analytical Instruments (3826) 042052042
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1462948 Anders Frank Wilson 940 Winter Street
Waltham MA 02451
Please See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-12-07 41,439 $26.15 106,581 No 4 M Direct
Common Stock Acquisiton 2017-12-07 29,052 $33.87 135,633 No 4 M Direct
Common Stock Disposition 2017-12-07 37,535 $70.14 65,142 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock NQ Stock Option (right to buy) Disposition 2017-12-07 41,439 $0.00 41,439 $26.15
Common Stock NQ Stock Option (right to buy) Disposition 2017-12-07 29,052 $0.00 29,052 $33.87
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-02-07 No 4 M Direct
0 2020-02-05 No 4 M Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Mr. Wilson on November 7, 2017.
  2. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $70.00 to $70.40. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  3. The Reporting Person's direct holdings include shares acquired pursuant to the Reporting Person's (i) election to defer stock and/or compensation into the Deferred Compensation Plan, and/or (ii) reinvestment of dividends relating to the Reporting Person's account.
  4. This option became exercisable in three equal annual installments beginning on February 7, 2013, which was the first anniversary of the date on which the option was granted.
  5. This option became exercisable in three equal annual installments beginning on February 5, 2014, which was the first anniversary of the date on which the option was granted.